Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 96,000 shares at $48.86 ($4.7M) on 2019-02-01, disclosed to the SEC on 2019-02-05.
Open-market sale of $4.7M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.86 | 27,660 | $1.4M | 28.6% |
| 2 | $48.86 | 27,660 | $1.4M | 28.6% |
| 3 | $49.51 | 9,840 | $487K | 10.3% |
| 4 | $49.51 | 9,840 | $487K | 10.3% |
| 5 | $49.53 | 21,000 | $1.0M | 22.0% |
| Total | $49.14 avg | 96,000 |
| $4.7M |
| 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |